Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Trine Juhler-Nøttrup is active.

Publication


Featured researches published by Trine Juhler-Nøttrup.


Acta Oncologica | 2008

Interfractional changes in tumour volume and position during entire radiotherapy courses for lung cancer with respiratory gating and image guidance

Trine Juhler-Nøttrup; S. Korreman; Anders N. Pedersen; Gitte Fredberg Persson; Lasse Rye Aarup; Håkan Nyström; Mikael Olsen; Nikolai Tarnavski; Lena Specht

Introduction. With the purpose of implementing gated radiotherapy for lung cancer patients, this study investigated the interfraction variations in tumour size and internal displacement over entire treatment courses. To explore the potential of image guided radiotherapy (IGRT) the variations were measured using a set-up strategy based on imaging of bony landmarks and compared to a strategy using in room lasers, skin tattoos and cupper landmarks. Materials and methods. During their six week treatment course of 60Gy in 2Gy fractions, ten patients underwent 3 respiratory gated CT scans. The tumours were contoured on each CT scan to evaluate the variations in volumes and position. The lung tumours and the mediastinal tumours were contoured separately. The positional variations were measured as 3D mobility vectors and correlated to matching of the scans using the two different strategies. Results. The tumour size was significantly reduced from the first to the last CT scan. For the lung tumours the reduction was 19%, p=0.03, and for the mediastinal tumours the reduction was 34%, p=0.0007. The mean 3D mobility vector and the SD for the lung tumours was 0.51cm (±0.21) for matching using bony landmarks and 0.85cm (±0.54) for matching using skin tattoos. For the mediastinal tumours the corresponding vectors and SDs were 0.55cm (±0.19) and 0.72cm (±0.43). The differences between the vectors were significant for the lung tumours p=0.004. The interfractional overlap of lung tumours was 80–87% when matched using bony landmarks and 70–76% when matched using skin tattoos. The overlap of the mediastinal tumours were 60–65% and 41–47%, respectively. Conclusions. Despite the use of gating the tumours varied considerably, regarding both position and volume. The variations in position were dependent on the set-up strategy. Set-up using IGRT was superior to set-up using skin tattoos.


Acta Oncologica | 2008

The role of image guidance in respiratory gated radiotherapy

S. Korreman; Trine Juhler-Nøttrup; Gitte Fredberg Persson; Anders N. Pedersen; Marika Enmark; Håkan Nyström; Lena Specht

Respiratory gating for radiotherapy beam delivery is a widely available technique, manufactured and sold by most of the major radiotherapy machine vendors. Respiratory gated beam delivery is intended to limit the irradiation of tumours moving with respiration to selected parts of the respiratory cycle, and thereby enable dose escalation and/or reduction of dose to organs at risk. Without adequate use of respiratory correlated image guidance on a regular basis, respiratory beam gating may however have a detrimental effect on target coverage. Image guidance of tumour respiratory motion is therefore of utmost importance for the safe introduction of respiratory gating. In this short overview, suitable image guidance strategies for respiratory gated radiotherapy are reviewed for two cancer sites; breast cancer and lung tumours.


International Journal of Radiation Oncology Biology Physics | 2012

Respiration-Correlated Image Guidance Is the Most Important Radiotherapy Motion Management Strategy for Most Lung Cancer Patients

S. Korreman; Gitte Fredberg Persson; Ditte Eklund Nygaard; Carsten Brink; Trine Juhler-Nøttrup

PURPOSE The purpose of this study was to quantify the effects of four-dimensional computed tomography (4DCT), 4D image guidance (4D-IG), and beam gating on calculated treatment field margins in a lung cancer patient population. MATERIALS AND METHODS Images were acquired from 46 lung cancer patients participating in four separate protocols at three institutions in Europe and the United States. Seven patients were imaged using fluoroscopy, and 39 patients were imaged using 4DCT. The magnitude of respiratory tumor motion was measured. The required treatment field margins were calculated using a statistical recipe (van Herk M, et al. Int J Radiat Oncol Biol Phys 2000;474:1121-1135), with magnitudes of all uncertainties, except respiratory peak-to-peak displacement, the same for all patients, taken from literature. Required margins for respiratory motion management were calculated using the residual respiratory tumor motion for each patient for various motion management strategies. Margin reductions for respiration management were calculated using 4DCT, 4D-IG, and gated beam delivery. RESULTS The median tumor motion magnitude was 4.4 mm for the 46 patients (range 0-29.3 mm). This value corresponded to required treatment field margins of 13.7 to 36.3 mm (median 14.4 mm). The use of 4DCT, 4D-IG, and beam gating required margins that were reduced by 0 to 13.9 mm (median 0.5 mm), 3 to 5.2 mm (median 5.1 mm), and 0 to 7 mm (median 0.2 mm), respectively, to a total of 8.5 to 12.4 mm (median 8.6 mm). CONCLUSION A respiratory management strategy for lung cancer radiotherapy including planning on 4DCT scans and daily image guidance provides a potential reduction of 37% to 47% in treatment field margins. The 4D image guidance strategy was the most effective strategy for >85% of the patients.


Radiotherapy and Oncology | 2008

Respiratory gated beam delivery cannot facilitate margin reduction, unless combined with respiratory correlated image guidance

S. Korreman; Trine Juhler-Nøttrup; Arthur L. Boyer


Radiotherapy and Oncology | 2009

The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: Implications for tumour coverage

Lasse Rye Aarup; Alan E. Nahum; Christina Zacharatou; Trine Juhler-Nøttrup; Tommy Knöös; Håkan Nyström; Lena Specht; Elinore Wieslander; S. Korreman


Journal of Clinical Oncology | 2017

Long-term benefit of niraparib treatment of recurrent ovarian cancer (OC).

Ursula A. Matulonis; Jørn Herrstedt; Anna V. Tinker; Frederik Marmé; Andrés Redondo; Elsa Kalbacher; Jonathan A. Ledermann; Joanna Pikiel; René dePont Christensen; Jonathan S. Berek; Trine Juhler-Nøttrup; Amit M. Oza; Werner Meier; Marta Gil-Martin; Anne-Claire Hardy-Bessard; Bradley J. Monk; Per Rosenberg; Robert M. Wenham; Sebastien J. Hazard; Mansoor Raza Mirza; Nova Investigators


Journal of Clinical Oncology | 2015

Preliminary phase II results of selinexor, an oral selective inhibitor of nuclear export in patients with heavily pretreated gynecological cancers

Ignace Vergote; Bente Lund; H. Havsteen; Zaza Ujmajuridze; Karin Leunen; Charlotte Aaquist Haslund; Trine Juhler-Nøttrup; Henrik Roed; Tami Rashal; Anne L Kranich; Yosef Landesman; Jean-Richard Saint-Martin; Robert W. Carlson; Sharon Shacham; Michael Kauffman; Mansoor Raza Mirza


Women's Health | 2014

Impact of ultrasound probe pressure on uterine positional displacement in gynecologic cancer patients.

Mariwan Baker; Trine Juhler-Nøttrup; Claus F. Behrens


Journal of Clinical Oncology | 2017

Combination chemotherapy with nintedanib/placebo for patients with advanced or recurrent endometrial cancer: The NSGO ENGOT-EN1/FANDANGO trial.

Mansoor Raza Mirza; Johanna Mäenpää; Elena Ioana Braicu; Ignace Vergote; Dominique Berton-Rigaud; Per Rosenberg; Jens Huober; Hannelore Denys; Florence Joly Lobbedez; Gunnar B. Kristensen; Toralf Reimer; Frédéric Kridelka; Anne Floquet; Anja Ør Knudsen; Bahriye Aktas; Jean-François Baurain; Philippe Follana; Trine Juhler-Nøttrup; Christina Jederud; Jalid Sehouli


Journal of Clinical Oncology | 2017

Palbociclib versus placebo in combination with letrozole for patients with advanced or recurrent endometrial cancer: The NSGO ENGOT-EN3/PALEO trial.

Mansoor Raza Mirza; Vanda Salutari; Cesar Mendiola; Jalid Sehouli; René dePont Christensen; Line Bjørge; Sandro Pignata; Marta Gil-Martin; Radoslav Chekerov; Gitte-Betina Nyvang; Domenica Lorusso; Maria Pilar Barretina-Ginesta; F Marmé; Graziana Ronzino; M Jesus Rubio; Ingo B. Runnebaum; Trine Juhler-Nøttrup; Joan Løhndorf; Annika Auranen

Collaboration


Dive into the Trine Juhler-Nøttrup's collaboration.

Top Co-Authors

Avatar

Mansoor Raza Mirza

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

S. Korreman

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Lena Specht

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Håkan Nyström

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Ignace Vergote

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Anders N. Pedersen

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H. Havsteen

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Lasse Rye Aarup

Copenhagen University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge